Digipath, Inc. (DIGP)

$0.0116

-0.00 (-6.45%)
Rating:
Recommendation:
-
Symbol DIGP
Price $0.0116
Beta 1.015
Volume Avg. 0.08M
Market Cap 0.872M
Shares () -
52 Week Range 0.0095-0.06
1y Target Est -
DCF Unlevered DIGP DCF ->
DCF Levered DIGP LDCF ->
ROE 70.58% Strong Buy
ROA -41.26% Strong Sell
Operating Margin -
Debt / Equity -232.73% Sell
P/E -
P/B -0.48 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Todd A. Peterson CPA
Healthcare
Diagnostics & Research
Other OTC

Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its labs screen medicinal and recreational cannabis for potentially harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.